April - 2020
| Previous Next | Showing Journal 4 of 10 |
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19B Cao, Y Wang, D Wen, etal NEJM, 2020, online first This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
April |
Previous Comments
No Comments yet.
Comment
This urgent, open-label RCT, tested the efficacy of 14-days of lopinavir-ritonavir + standard care vs standard care alone in 199 hospitalised adult patients with SARS-CoV-2 patients and severe acute lung injury (P:F ratio <300).
In short;
...